Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Sprog: | English |
| Udgivet: |
Oxford University Press
2022
|
| _version_ | 1826310331316568064 |
|---|---|
| author | Coates, LC Garrood, T Gullick, N Helliwell, P Kent, T Marks, J Tillett, W Kaur-Papadakis, D Tahir, H van Haaren, S McInnes, I |
| author_facet | Coates, LC Garrood, T Gullick, N Helliwell, P Kent, T Marks, J Tillett, W Kaur-Papadakis, D Tahir, H van Haaren, S McInnes, I |
| author_sort | Coates, LC |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T07:48:50Z |
| format | Journal article |
| id | oxford-uuid:ab055b8c-a841-41d4-b4e4-854dba67eba0 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:48:50Z |
| publishDate | 2022 |
| publisher | Oxford University Press |
| record_format | dspace |
| spelling | oxford-uuid:ab055b8c-a841-41d4-b4e4-854dba67eba02023-07-03T08:56:21ZUpadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARCJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ab055b8c-a841-41d4-b4e4-854dba67eba0EnglishSymplectic ElementsOxford University Press2022Coates, LCGarrood, TGullick, NHelliwell, PKent, TMarks, JTillett, WKaur-Papadakis, DTahir, Hvan Haaren, SMcInnes, I |
| spellingShingle | Coates, LC Garrood, T Gullick, N Helliwell, P Kent, T Marks, J Tillett, W Kaur-Papadakis, D Tahir, H van Haaren, S McInnes, I Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC |
| title | Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC |
| title_full | Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC |
| title_fullStr | Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC |
| title_full_unstemmed | Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC |
| title_short | Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC |
| title_sort | upadacitinib response rates in patients with psoriatic arthritis enrolled in the select psa 1 and select psa 2 trials assessed according to modified psarc |
| work_keys_str_mv | AT coateslc upadacitinibresponseratesinpatientswithpsoriaticarthritisenrolledintheselectpsa1andselectpsa2trialsassessedaccordingtomodifiedpsarc AT garroodt upadacitinibresponseratesinpatientswithpsoriaticarthritisenrolledintheselectpsa1andselectpsa2trialsassessedaccordingtomodifiedpsarc AT gullickn upadacitinibresponseratesinpatientswithpsoriaticarthritisenrolledintheselectpsa1andselectpsa2trialsassessedaccordingtomodifiedpsarc AT helliwellp upadacitinibresponseratesinpatientswithpsoriaticarthritisenrolledintheselectpsa1andselectpsa2trialsassessedaccordingtomodifiedpsarc AT kentt upadacitinibresponseratesinpatientswithpsoriaticarthritisenrolledintheselectpsa1andselectpsa2trialsassessedaccordingtomodifiedpsarc AT marksj upadacitinibresponseratesinpatientswithpsoriaticarthritisenrolledintheselectpsa1andselectpsa2trialsassessedaccordingtomodifiedpsarc AT tillettw upadacitinibresponseratesinpatientswithpsoriaticarthritisenrolledintheselectpsa1andselectpsa2trialsassessedaccordingtomodifiedpsarc AT kaurpapadakisd upadacitinibresponseratesinpatientswithpsoriaticarthritisenrolledintheselectpsa1andselectpsa2trialsassessedaccordingtomodifiedpsarc AT tahirh upadacitinibresponseratesinpatientswithpsoriaticarthritisenrolledintheselectpsa1andselectpsa2trialsassessedaccordingtomodifiedpsarc AT vanhaarens upadacitinibresponseratesinpatientswithpsoriaticarthritisenrolledintheselectpsa1andselectpsa2trialsassessedaccordingtomodifiedpsarc AT mcinnesi upadacitinibresponseratesinpatientswithpsoriaticarthritisenrolledintheselectpsa1andselectpsa2trialsassessedaccordingtomodifiedpsarc |